AstraZeneca today announced that ticagrelor, an oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised “Guidelines on the Management ...

Failing to use guidelines is an antiquated and inappropriate pattern of practice. Cochair Dr Sidney Smith (University of North Carolina, Chapel Hill) said, "Based on the results of large clinical ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...